rs3824519

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006180.6(NTRK2):​c.1938-194C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0903 in 152,224 control chromosomes in the GnomAD database, including 716 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.090 ( 716 hom., cov: 33)

Consequence

NTRK2
NM_006180.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.79

Publications

5 publications found
Variant links:
Genes affected
NTRK2 (HGNC:8032): (neurotrophic receptor tyrosine kinase 2) This gene encodes a member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to cell differentiation. Mutations in this gene have been associated with obesity and mood disorders. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
NTRK2 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 58
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • obesity, hyperphagia, and developmental delay
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 9-84955089-C-T is Benign according to our data. Variant chr9-84955089-C-T is described in ClinVar as Benign. ClinVar VariationId is 1269737.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.127 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NTRK2NM_006180.6 linkc.1938-194C>T intron_variant Intron 16 of 18 ENST00000277120.8 NP_006171.2 Q16620-4A0A024R230Q5VWE5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NTRK2ENST00000277120.8 linkc.1938-194C>T intron_variant Intron 16 of 18 1 NM_006180.6 ENSP00000277120.3 Q16620-4

Frequencies

GnomAD3 genomes
AF:
0.0902
AC:
13726
AN:
152106
Hom.:
712
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.129
Gnomad AMI
AF:
0.0932
Gnomad AMR
AF:
0.120
Gnomad ASJ
AF:
0.0274
Gnomad EAS
AF:
0.115
Gnomad SAS
AF:
0.0418
Gnomad FIN
AF:
0.0512
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0711
Gnomad OTH
AF:
0.0798
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0903
AC:
13748
AN:
152224
Hom.:
716
Cov.:
33
AF XY:
0.0889
AC XY:
6615
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.129
AC:
5372
AN:
41514
American (AMR)
AF:
0.121
AC:
1843
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0274
AC:
95
AN:
3470
East Asian (EAS)
AF:
0.116
AC:
597
AN:
5168
South Asian (SAS)
AF:
0.0416
AC:
201
AN:
4826
European-Finnish (FIN)
AF:
0.0512
AC:
544
AN:
10618
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0711
AC:
4833
AN:
68012
Other (OTH)
AF:
0.0789
AC:
167
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
631
1262
1893
2524
3155
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0781
Hom.:
369
Bravo
AF:
0.0981
Asia WGS
AF:
0.0950
AC:
332
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 21, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.21
DANN
Benign
0.54
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3824519; hg19: chr9-87570004; API